Potentially active compounds that improve PAD through angiogenesis: A review.

Liu, Zi-Bo; Fan, Xin-Yun; Wang, Chen-Wei; Ye, Xun; Wu, Chun-Jie

Liu, Zi-Bo; Fan, Xin-Yun; Wang, Chen-Wei; Ye, Xun; Wu, Chun-Jie.

Afiliação

Liu ZB; State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Fan XY; State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Wang CW; State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Ye X; State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Wu CJ; State Key Laboratory of Southwestern Chinese Medicine Resources, Innovative Institute of Chinese Medicine and Pharmacy/Academy for Interdiscipline, Chengdu Univesity of Traditional Chinese Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China. Electronic address: wuchun

Biomed Pharmacother ; 168: 115634, 2023 Dec.

Article em En | MEDLINE | ID: mdl-37879211

Assuntos

Produtos Biológicos; Diabetes Mellitus; Doença Arterial Periférica; Humanos; Células Endoteliais; Produtos Biológicos/farmacologia; Diabetes Mellitus/tratamento farmacológico; Doença Arterial Periférica/tratamento farmacológico

Palavras-chave

20(S)-protopanaxadiol (PubChem CID:11213350); Angiogenesis; Apabetalone (PubChem CID:135564749); Astragaloside IV (PubChem CID:13943297); Aucubin (PubChem CID:91458); Bavachalcone (PubChem CID:6450879) Sitagliptin (PubChem CID:4369359); Caffeine (PubChem CID:2519); Cilostazol (PubChem CID:2754); Curcumin (PubChem CID:969516); Dapagliflozin (PubChem CID:9887712); Diabetes; Empagliflozin (PubChem CID:11949646); Ginsenoside Rg5 (PubChem CID:11550001); Hindlimb ischemia; Liraglutide (PubChem CID:16134956); Naringin (PubChem CID:442428); Natural products; Oroxylin A (PubChem CID:5320315); PAD; Quercetin (PubChem CID:5280343); Resveratrol (PubChem CID:445154); Rivaroxaban(PubChem CID:9875401); Salidroside (PubChem CID:159278); Synthetic compounds

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Diabetes Mellitus / Doença Arterial Periférica Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google